Topiramate-induced suicidality [5]

Canadian Journal of Psychiatry

Volumn 48, Issue 2, 2003, Pages 127-128

  Abraham, G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; LEVOTHYROXINE; LITHIUM CARBONATE; TOPIRAMATE;

ADULT; BIPOLAR DISORDER; CASE REPORT; CLINICAL FEATURE; DEPRESSION; DRUG INDUCED DISEASE; DRUG RESPONSE; FEMALE; HUMAN; HYPOTHYROIDISM; LETTER; SKIN DISEASE; SUICIDAL BEHAVIOR; SYMPTOM;

EID: 0037356412     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: 10.1177/070674370304800214     Document Type: Letter

References (6)

1. McElroy SL, Suppes T, Keck PE, Frye MA, Denicoff KD, Altshuler LL, and others. Open-label adjunctive topiramate in the treatment of bipolar disorders. Biol Psychiatry 2000;47:1025-33.
2. Khan A, Faught E, Gilliam F, Kuzniecky R. Acute psychotic symptoms induced by topiramate. Seizure 1999;8:235-7.
3. Klufas A, Thompson D. Topiramate-induced depression. J Clin Psychiatry 2001;62:653.
4. Chengappa KN, Rathore D, Levine J, Atzert R, Solai L, Parepally H, and others. Topiramate as add-on treatment for patients with bipolar mania. Bipolar Disord 1999;1:42-53.
5. Ghaemi SN, Manwani SG, Katzow JJ, Goodwin FK. Topiramate treatment of bipolar spectrum disorders: a retrospective chart review. Ann Clin Psychiatry 2001;13:185-9.
6. Andrade C. Confusion and dysphoria with low-dose topiramate in a patient with bipolar disorder. Bipolar Disord 2001;3:211-2.